Cargando…

Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016)

BACKGROUND: Cancer-related causes of death (cancer CoD) are the main etiologies of death in cancer patients. Recent increase in survival rates of cancer patients resulted in higher risk of dying from causes other than cancer, called competing causes of death (competing CoD). We aim to characterize c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zare, Mostafa, Hasanpour-Heidari, Susan, Semnani, Shahryar, Fazel, Abdolreza, Sedaghat, Seyed Mehdi, Semnani, Yasamin, Mansuri, Seyed Mohsen, Gholami, Masoomeh, Araghi, Marzieh, Roshandel, Gholamreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858227/
https://www.ncbi.nlm.nih.gov/pubmed/34710989
http://dx.doi.org/10.31557/APJCP.2021.22.10.3137
_version_ 1784654204720119808
author Zare, Mostafa
Hasanpour-Heidari, Susan
Semnani, Shahryar
Fazel, Abdolreza
Sedaghat, Seyed Mehdi
Semnani, Yasamin
Mansuri, Seyed Mohsen
Gholami, Masoomeh
Araghi, Marzieh
Roshandel, Gholamreza
author_facet Zare, Mostafa
Hasanpour-Heidari, Susan
Semnani, Shahryar
Fazel, Abdolreza
Sedaghat, Seyed Mehdi
Semnani, Yasamin
Mansuri, Seyed Mohsen
Gholami, Masoomeh
Araghi, Marzieh
Roshandel, Gholamreza
author_sort Zare, Mostafa
collection PubMed
description BACKGROUND: Cancer-related causes of death (cancer CoD) are the main etiologies of death in cancer patients. Recent increase in survival rates of cancer patients resulted in higher risk of dying from causes other than cancer, called competing causes of death (competing CoD). We aim to characterize competing CoD among cancer patients in Golestan province, Northern Iran. METHODS: Data on cancer incidence was obtained from the Golestan population-based cancer registry (GPCR) dataset. Data on causes of death was obtained from the Golestan death registry (GDR) dataset. Using a linkage method between the GPCR and GDR dataset, we prepared the study dataset including data on vital status and causes of death in our cancer patients. The proportions of cancer CoD and competing CoD were calculated. Multivariate logistic regression analysis was considered to assess the relationship between competing CoD and other variables. RESULTS: Overall, 4,184 cancer patients died in the study population, including 2,488 men (59.9%). Cause of death in 3,455 cases was cancer and 729 cases (17.4%) died due to competing CoD. Ischemic heart disease (40.7%) was the most common competing CoD in our population. Higher survival rate was the strongest variable related to the competing CoD (adjusted OR=1.91; 95%CI: 1.61-2.26). Residence area, age group and year of death were other indicators of competing CoD in our population. CONCLUSION: Our results suggest high rates of competing CoD in our cancer patients. Competing CoD should be mentioned in cancer control planning both in clinical practice as well as in public health policy making.
format Online
Article
Text
id pubmed-8858227
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-88582272022-04-04 Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016) Zare, Mostafa Hasanpour-Heidari, Susan Semnani, Shahryar Fazel, Abdolreza Sedaghat, Seyed Mehdi Semnani, Yasamin Mansuri, Seyed Mohsen Gholami, Masoomeh Araghi, Marzieh Roshandel, Gholamreza Asian Pac J Cancer Prev Research Article BACKGROUND: Cancer-related causes of death (cancer CoD) are the main etiologies of death in cancer patients. Recent increase in survival rates of cancer patients resulted in higher risk of dying from causes other than cancer, called competing causes of death (competing CoD). We aim to characterize competing CoD among cancer patients in Golestan province, Northern Iran. METHODS: Data on cancer incidence was obtained from the Golestan population-based cancer registry (GPCR) dataset. Data on causes of death was obtained from the Golestan death registry (GDR) dataset. Using a linkage method between the GPCR and GDR dataset, we prepared the study dataset including data on vital status and causes of death in our cancer patients. The proportions of cancer CoD and competing CoD were calculated. Multivariate logistic regression analysis was considered to assess the relationship between competing CoD and other variables. RESULTS: Overall, 4,184 cancer patients died in the study population, including 2,488 men (59.9%). Cause of death in 3,455 cases was cancer and 729 cases (17.4%) died due to competing CoD. Ischemic heart disease (40.7%) was the most common competing CoD in our population. Higher survival rate was the strongest variable related to the competing CoD (adjusted OR=1.91; 95%CI: 1.61-2.26). Residence area, age group and year of death were other indicators of competing CoD in our population. CONCLUSION: Our results suggest high rates of competing CoD in our cancer patients. Competing CoD should be mentioned in cancer control planning both in clinical practice as well as in public health policy making. West Asia Organization for Cancer Prevention 2021-10 /pmc/articles/PMC8858227/ /pubmed/34710989 http://dx.doi.org/10.31557/APJCP.2021.22.10.3137 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zare, Mostafa
Hasanpour-Heidari, Susan
Semnani, Shahryar
Fazel, Abdolreza
Sedaghat, Seyed Mehdi
Semnani, Yasamin
Mansuri, Seyed Mohsen
Gholami, Masoomeh
Araghi, Marzieh
Roshandel, Gholamreza
Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016)
title Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016)
title_full Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016)
title_fullStr Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016)
title_full_unstemmed Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016)
title_short Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016)
title_sort analysis of competing risks of causes of death in cancer patients from golestan, iran over twelve years (2004-2016)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858227/
https://www.ncbi.nlm.nih.gov/pubmed/34710989
http://dx.doi.org/10.31557/APJCP.2021.22.10.3137
work_keys_str_mv AT zaremostafa analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016
AT hasanpourheidarisusan analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016
AT semnanishahryar analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016
AT fazelabdolreza analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016
AT sedaghatseyedmehdi analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016
AT semnaniyasamin analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016
AT mansuriseyedmohsen analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016
AT gholamimasoomeh analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016
AT araghimarzieh analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016
AT roshandelgholamreza analysisofcompetingrisksofcausesofdeathincancerpatientsfromgolestaniranovertwelveyears20042016